Letters to the Editor
Evaluation of Chronic Cough Should Consider Cannabis Use
Am Fam Physician. 2012 Apr 1;85(7):680.
Original Article: Evaluation of the Patient with Chronic Cough
Issue Date: October 15, 2011
Available at: http://www.aafp.org/afp/2011/1015/p887.html
to the editor: We would like to commend Drs. Benich and Carek for their thoughtful review of the evaluation of chronic cough. The authors pointed out that cigarette smoke is a major factor to consider as a cough-evoking irritant. We are writing to call attention to another potential irritant that should be considered during a comprehensive evaluation of chronic cough: cannabis smoke.
Cannabis is the most widely used illicit substance in the United States, with 17.4 million past-month users and an estimated 4.6 million persons smoking cannabis on a daily or almost daily basis in 2010.1,2 Many of these persons will be evaluated for various reasons in a primary care setting. For example, a study of 236 consecutive urban primary care patients presenting for routine evaluation found a 5.1 percent prevalence of cannabis use within the past 90 days.3 Because respiratory symptoms, including chronic cough, are among the most common medical consequences of long-term cannabis use,4 primary care physicians may see patients with chronic cough in whom cannabis use is a contributing factor.
Direct inquiry about cannabis use can be integrated with assessment for other potential respiratory irritants. By combining questions about cannabis and tobacco use, the relevant history may be obtained in a nonjudgmental manner. Assessment can also be enhanced by brief, validated screening methods, such as the Alcohol, Smoking, and Substance Involvement Screening Test from the World Health Organization,3 which is recommended by the National Institute on Drug Abuse for use in general medical settings.5 An online version of this tool (available at http://www.drugabuse.gov/nmassist/) guides physicians through a short series of screening questions and generates a substance involvement score that suggests the level of intervention needed.
Chronic cough is an important and common clinical problem. Awareness of the prevalence, consequences, and strategies for identification of long-term cannabis use will equip physicians to be better able to evaluate and treat patients with chronic cough.
Author disclosure: No relevant financial affiliations to disclose.
1. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the future: national survey results on drug use, 1975–2010. Volume II: college students and adults ages 19–50. http://www.monitoringthefuture.org/pubs/monographs/mtf-vol2_2010.pdf. Accessed December 9, 2011.
2. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: summary of national findings. http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm. Accessed December 9, 2011.
3. Lee JD, Delbanco B, Wu E, Gourevitch MN. Substance use prevalence and screening instrument comparisons in urban primary care. Subst Abus. 2011;32(3):128–34.
4. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2007;167(3):221–8.
5. National Institute on Drug Abuse. Screening for drug use in general medical settings: resource guide. http://www.drugabuse.gov/publications/resource-guide. Accessed November 17, 2011.
editor's note: This letter was sent to the authors of “Evaluation of the Patient with Chronic Cough,” who declined to reply.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2012 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions